image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Primary Recommendation

Bespak - Pfizer's Exubera to excite shares

February 2002

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BPK
Over the month we met the management of Bespak, which assembles and sells a range of customised valves and actuators for asthma inhalers and also provides a range of fee-based outsourcing services, managing regulatory and development aspects for new devices and then manufacturing them once approved. Once a star of the 90s, thecompany has spent the last few years a shadow of its formerlyfast-growing self. But there are signs of strong growth returning. Theincidence of respiratory disease continues to grow, whilst there is anincreasing trend towards delivering drugs via the lungs rather thanorally or by injection. Meanwhile,  an increasing interest inoutsourcing manufacturing and development of devices is increasing the ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Bespak - Customer Pfizer close to Exubera filing (May 2002)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW